10.1 Central Line-Associated Bloodstream Infections & Mechanical Risks

10.1 Central Line-Associated Bloodstream Infections & Mechanical Risks

Clinical Core: Central venous access devices (CVADs) provide the essential vascular conduit for parenteral nutrition (PN) delivery, yet they introduce profound infectious and mechanical risks. Central line-associated bloodstream infection (CLABSI) carries substantial attributable mortality ($12\%\text{ to }25\%$) and excess healthcare expenditure. Preventing infectious morbidity mandates adherence to evidence-based insertion and maintenance bundles, reserving a dedicated lumen exclusively for PN, and performing standardized hub disinfection. When catheter infections occur, immediate line removal is non-negotiable for virulent pathogens such as Candida species and Staphylococcus aureus. Concurrently, clinicians must master the emergency management of mechanical hazards, including acute venous air embolism via the Durant maneuver and catheter occlusions using targeted biochemical and enzymatic clearance protocols.

---

CLABSI Epidemiology, Surveillance Definitions & Microbial Etiology

Central line-associated bloodstream infections represent one of the most hazardous adverse events encountered in patients dependent on parenteral nutrition. In the OpenExamPrep guide curriculum, clinicians must clearly distinguish between epidemiologic surveillance definitions and clinical diagnostic definitions.

CDC NHSN Surveillance Definition

The Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) defines a CLABSI as a primary Laboratory-Confirmed Bloodstream Infection (LCBI) where an eligible central venous access line was in place for greater than 2 calendar days on the date of the event (with day of device placement being Day 1), and the line was present on the date of event or removed the calendar day before.

To meet the LCBI diagnostic threshold, the clinical presentation must fulfill one of two distinct criteria:

1. Criterion 1 (Recognized Pathogen): A patient has a recognized pathogen cultured from one or more blood specimens (e.g., Staphylococcus aureus, Enterococcus species, Escherichia coli, Pseudomonas aeruginosa, Klebsiella species, or Candida species) AND the organism is not related to an infection at another anatomical site.
2. Criterion 2 (Common Commensal): A patient has at least one systemic sign of infection (fever $> 38.0^\circ\text{C}$, chills, or hypotension) AND the same common skin commensal (e.g., coagulase-negative staphylococci, Corynebacterium species, Bacillus species, or micrococci) is cultured from two or more blood sets drawn on separate occasions within a 2-day period.

Catheter-Related Bloodstream Infection (CRBSI) & Differential Time to Positivity

While CLABSI serves as a broader surveillance metric, Catheter-Related Bloodstream Infection (CRBSI) is a precise clinical and microbiological diagnosis attributing infection directly to the catheter. Diagnostic confirmation without catheter removal is established using paired quantitative blood cultures or Differential Time to Positivity (DTP):

• Differential Time to Positivity (DTP): Blood samples of identical volume are drawn simultaneously from the central venous catheter hub and a peripheral percutaneous venipuncture. If the microbial culture drawn from the catheter lumen turns positive at least 2 hours (120 minutes) earlier than the peripheral blood culture, a catheter source is confirmed with high sensitivity and specificity.
• Quantitative Colony Counts: A colony count from blood drawn through the catheter lumen that is $\ge 3\text{- to }5\text{-fold greater}$ than the colony count from a simultaneous peripheral blood sample confirms CRBSI.

Microbial Spectrum in Parenteral Nutrition

Microorganisms colonize catheters via two primary routes: extraluminal migration along the outer catheter tract from the skin insertion site (common in lines placed $< 14\text{ days}$), and intraluminal contamination through manipulated hubs and connectors (predominant in long-term lines $> 14\text{ days}$):

---

The Central Line Insertion Bundle (IHI / CDC Guidelines)

Adherence to the Institute for Healthcare Improvement (IHI) and CDC Central Line Insertion Bundle reduces line-associated infection rates by over $70\%$. The insertion bundle comprises five standardized, evidence-based practices:

                  [ CENTRAL LINE INSERTION BUNDLE ]
                                  │
  ┌───────────────┬───────────────┼───────────────┬───────────────┐
  ▼               ▼               ▼               ▼               ▼
[ Hand ]      [ Maximal ]     [ Alcoholic ]   [ Optimal Site ] [ Daily ]
[ Hygiene ]   [ Barriers ]    [ CHG Prep ]    [ Selection ]    [ Necessity ]
Strict soap/  Cap, mask,      >0.5% CHG in    Subclavian vein  Daily evaluation
water or      sterile gown,   70% alcohol;    preferred; avoid for immediate
alcohol rub   gloves, full    full air dry    femoral vein in  line removal
prior to site drape over      (≥2 minutes)    adult patients   when no longer
prep          patient         before puncture                  required

1. Strict Hand Hygiene: Decontamination using soap and water or alcohol-based hand rub prior to palpation, skin preparation, and catheter insertion.
2. Maximal Sterile Barrier Precautions: The proceduralist and all assisting personnel must wear a surgical cap, mask, sterile gown, and sterile gloves. The entire patient must be covered from head to toe with a large, sterile full-body drape.
3. Chlorhexidine Skin Antisepsis: The insertion site must be prepared with an alcoholic chlorhexidine gluconate solution containing $> 0.5\%$ chlorhexidine in $70\%$ isopropyl alcohol. Application requires active, repeated back-and-forth friction scrubbing for at least 30 seconds to penetrate deeper epidermal layers, followed by complete air drying (at least 2 minutes). Povidone-iodine ($10\%$) is reserved exclusively for confirmed chlorhexidine hypersensitivity and mandates a full 2-minute contact air-dry time.
4. Optimal Site Selection: In adult patients, the subclavian vein is strongly preferred over the internal jugular and femoral veins. The subclavian site has the lowest microbial skin colonization and lowest historical rate of catheter-related thrombosis and infection. The femoral vein is associated with the highest risk of colonization, groin moisture, fecal contamination, and deep vein thrombosis and must be strictly avoided in adult patients. While the internal jugular site carries higher colonization than the subclavian, it is preferred over subclavian access in patients with advanced renal disease to prevent subclavian vein stenosis, which destroys future ipsilateral arteriovenous fistula viability.
5. Daily Review of Line Necessity: Daily multidisciplinary assessment to ensure that non-essential lines are removed immediately.

---

The Central Line Maintenance Bundle

Once a central line is placed, the maintenance bundle governs daily operational safety:

Exclusive Dedicated Lumen for Parenteral Nutrition

Because PN formulations—particularly lipid emulsions—serve as rich microbial culture media, a dedicated single lumen must be reserved strictly for parenteral nutrition. This dedicated lumen must never be violated for routine blood sampling, transfusion of blood products, administration of intravenous push medications, piggyback drugs, or central venous pressure (CVP) monitoring. Violating the PN lumen multiplies luminal contamination rates.

Standardized "Scrub-the-Hub" Disinfection

The needleless injection cap or hub is the primary portal for intraluminal microbial entry. Prior to accessing any line lumen:

• Perform vigorous mechanical friction scrubbing of the access port diaphragm and threads for a full 10 to 15 seconds using $70\%$ isopropyl alcohol or alcoholic chlorhexidine.
• Allow the hub to air dry completely (5 to 15 seconds) before puncture. Wet alcohol carried into the lumen does not disinfect and can precipitate medication incompatibility.
• Passive disinfection caps containing $70\%$ isopropyl alcohol sponges provide continuous decontamination and should be applied to all inactive access valves.

Dressing Management Schedules

• Transparent Semi-Permeable Polyurethane Dressings: Allow continuous visual inspection of the insertion site; must be changed every 7 days, or immediately if the dressing becomes damp, loosened, soiled, or non-occlusive.
• Gauze Dressings: Used when active bleeding, oozing, or diaphoresis occurs at the puncture site; must be replaced at least every 48 hours and transitioned to a transparent dressing once the site is dry.
• Chlorhexidine-Impregnated Dressings/Sponge: The routine application of a chlorhexidine-impregnated sponge (e.g., Biopatch) or CHG-integrated transparent dressing is recommended for all central venous catheters in adult patients to suppress skin flora regrowth.

Administration Set and Tubing Changes

• 3-in-1 Total Nutrient Admixtures (containing lipids): Infusion tubing and in-line filters must be replaced every 24 hours due to rapid microbial growth support.
• 2-in-1 Solutions (lipids infused separately): Separate lipid tubing must be replaced every 12 to 24 hours; clear dextrose-amino acid tubing must be replaced at least every 72 to 96 hours (or every 24 hours per institutional compounded PN protocols).

---

Catheter Removal Versus Salvage Indications

When bacteremia or fungemia is suspected in a patient receiving PN, clinicians must weigh the risk of endovascular infection against the loss of vital venous access.

                    [ BLOODSTREAM INFECTION WITH CVAD ]
                                     │
        ┌────────────────────────────┴────────────────────────────┐
        ▼                                                         ▼
[ MANDATORY IMMEDIATE REMOVAL ]                           [ POTENTIAL SALVAGE ]
  • Pathogens:                                              • Pathogens:
    - Candida species (Fungemia)                              - Coagulase-negative Staph (uncomplicated)
    - Staphylococcus aureus                                   - Sensitive enteric Gram-negative bacilli
    - Pseudomonas aeruginosa                                • Clinical Requirements:
    - Multidrug-resistant GNRs, Mycobacteria                  - Hemodynamically stable
  • Complications:                                            - No tunnel/pocket infection or abscess
    - Septic shock / severe sepsis                            - No metastatic seeding or endocarditis
    - Suppurative thrombophlebitis                            - Limited remaining central access
    - Tunnel infection or pocket abscess                    • Management:
    - Persistent bacteremia >72 hours on targeted therapy     - Systemic IV antibiotics (10-14 days)
                                                              - Antibiotic lock therapy (ALT) or ELT

Absolute Indications for Immediate Catheter Removal

The Infectious Diseases Society of America (IDSA) guidelines mandate immediate catheter removal in the following circumstances:

1. Fungemia (Candida species): Catheter salvage in Candida bloodstream infections is associated with treatment failure and extreme mortality ($> 40\%\text{ to }50\%$). Candida produces thick, impermeable glucan-rich biofilms. The catheter must be promptly removed, followed by systemic antifungal therapy (e.g., an echinocandin such as caspofungin, micafungin, or anidulafungin) continued for at least 14 days after the first documented negative blood culture.
2. Virulent or Metastatic Bacterial Pathogens: Any bloodstream infection caused by Staphylococcus aureus (due to high rates of endocarditis and osteomyelitis), Pseudomonas aeruginosa, multidrug-resistant Gram-negative rods, or non-tuberculous mycobacteria.
3. Clinical Complications: Septic shock, hemodynamic instability, suppurative thrombophlebitis, endocarditis, or tunnel infection / port pocket abscess (erythema, induration, and tenderness tracking along the subcutaneous subcutaneous tunnel).
4. Persistent Infection: Persistent bacteremia or fungemia continuing $> 72\text{ hours}$ after the initiation of appropriate systemic antimicrobial therapy.

Catheter Salvage Strategies: Lock Therapy

Catheter salvage is reserved strictly for stable patients with uncomplicated bacteremia caused by coagulase-negative staphylococci or sensitive Gram-negative bacilli where vascular access is critically limited (e.g., end-stage intestinal failure with few remaining central veins):

• Antibiotic Lock Therapy (ALT): A high-concentration antimicrobial solution (typically 100 to 1,000 times the minimum inhibitory concentration, e.g., vancomycin $5\text{ mg/mL}$, daptomycin, gentamicin, or ciprofloxacin) combined with an anticoagulant (heparin or sodium citrate) is instilled into the catheter lumen. The volume must match the internal priming volume of the lumen (usually $1.5\text{ to }2.5\text{ mL}$) and remain dwelling for 12 to 24 hours daily for 10 to 14 days, administered concurrently with systemic intravenous antibiotics.
• Ethanol Lock Therapy (ELT): A $70\%$ ethyl alcohol solution instilled into the lumen for a 2- to 4-hour dwell. Ethanol non-specifically denatures microbial proteins and dissolves biofilm lipid membranes without generating bacterial resistance. Clinicians must verify catheter compatibility before using ethanol, as pure polyurethane or silicone lines may experience structural degradation or hub embrittlement with prolonged exposure.

---

Mechanical Catheter Complications

Beyond infectious risks, central venous catheters introduce severe mechanical hazards during insertion and ongoing maintenance.

Acute Insertion Hazards

• Pneumothorax and Hemothorax: Most frequently complicates subclavian vein catheterization ($1\%\text{ to }3\%$ incidence) due to direct pleural dome puncture by the introducer needle. Symptoms include acute pleuritic chest pain, dyspnea, tachypnea, and diminished breath sounds on the ipsilateral side. Diagnosis is confirmed via post-procedure upright chest radiograph or bedside thoracic ultrasound showing absence of lung sliding. Tension pneumothorax mandates immediate needle decompression followed by tube thoracostomy.
• Arterial Puncture: Inadvertent puncture of the carotid artery (during internal jugular cannulation) or subclavian artery. Puncture of the carotid artery is identified by pulsatile, bright red blood flash and requires immediate needle withdrawal and firm direct compression for at least 10 to 15 minutes. Puncture of the subclavian artery is particularly hazardous because the vessel resides beneath the clavicle and is anatomically non-compressible, predisposing to massive apical hemothorax or mediastinal hematoma.
• Catheter Malposition: The catheter tip should reside in the lower third of the superior vena cava at the cavoatrial junction (radiographically aligned with the right tracheobronchial angle or fifth to sixth thoracic vertebra). Malposition into the right atrium risks atrial wall perforation, cardiac tamponade, and lethal dysrhythmias. Malposition cephalad into the ipsilateral internal jugular or contralateral subclavian vein produces ear pain, facial swelling, chemical phlebitis from hypertonic PN infusions, and high rates of venous thrombosis.

Catheter-Related Venous Thrombosis (CRVT)

Catheter-related upper extremity deep vein thrombosis (UEDVT) involves the subclavian, axillary, or internal jugular veins. Intravascular foreign bodies cause endothelial injury, disrupt laminar blood flow, and induce localized platelet activation.

• Presentation: Unilateral ipsilateral arm swelling, pain, limb cyanosis or coolness, and visible dilation of superficial collateral veins across the chest and shoulder (Urschel sign).
• Diagnosis: Duplex ultrasonography of the internal jugular, subclavian, and axillary veins is the initial diagnostic modality of choice.
• Management Protocol: Therapeutic systemic anticoagulation (low-molecular-weight heparin or direct oral anticoagulants) must be initiated and continued for at least 3 months. The catheter does not require removal if it remains functional, non-infected, correctly positioned, and the patient's symptoms improve with anticoagulation. If anticoagulation is contraindicated, symptoms progress, or the line is non-functional, the catheter is removed after initiating anticoagulation.

Venous Air Embolism (VAE)

Venous air embolism represents an acute, catastrophic mechanical emergency. During spontaneous respiration, intrathoracic pressure is subatmospheric (negative relative to ambient atmosphere). If an access hub is left open, disconnected, or unclipped, or if a catheter is removed while the patient is upright, atmospheric air is sucked directly into the central venous circulation.

                    [ VENOUS AIR EMBOLISM MANAGEMENT ]
                                     │
  ┌──────────────────────────────────┴──────────────────────────────────┐
  ▼                                                                     ▼
[ 1. OCCLUDE THE AIR SOURCE ]                       [ 2. EXECUTE DURANT MANEUVER ]
  • Immediately clamp catheter lumen                  • Place patient in TRENDELENBURG
  • Cover open insertion site with                      (head down, feet elevated 15-30°)
    petrolatum gauze / occlusive dressing             • Rotate into LEFT LATERAL DECUBITUS
                                                      • Traps buoyant air bubble in RV apex,
                                                        relieving outflow tract obstruction
                                                                        │
  ┌─────────────────────────────────────────────────────────────────────┘
  ▼
[ 3. MEDICAL STABILIZATION & RESCUE ]
  • Administer 100% high-flow oxygen (promotes nitrogen reabsorption)
  • Perform emergent aspiration of air via central venous catheter
  • Rapid cardiopulmonary resuscitation / volume expansion if pulseless

• Pathophysiology & Presentation: The entrained air bolus travels rapidly into the right atrium and right ventricle, forming a foamy, compressible "air lock" in the right ventricular outflow tract (RVOT) and pulmonary arterial trunk. This completely obstructs right ventricular stroke volume, precipitating acute circulatory collapse, severe hypoxemia, acute cor pulmonale, and cardiogenic shock. Physical examination classically reveals a loud, churning, continuous precordial murmur termed the "mill-wheel murmur".
• Immediate Emergency Management:
  1. Occlude Entry: Immediately clamp the catheter, cover the open hub, or apply an occlusive petroleum-impregnated gauze over an open tract.
  2. The Durant Maneuver: Position the patient in Trendelenburg (head-down) and left lateral decubitus position. This geometry displaces the buoyant air bubble away from the right ventricular outflow tract toward the right ventricular apex, restoring blood flow into the pulmonary circulation.
  3. High-Flow Oxygen: Administer $100\%$ normobaric or hyperbaric oxygen. Hyperoxia accelerates the diffusion of nitrogen out of the air bubble into surrounding blood, drastically shrinking bubble diameter.
  4. Direct Aspiration: If a central line is in place within the right heart chambers, attempt immediate direct aspiration of air using a syringe.

Catheter Occlusion & Fibrin Sheath Management

Catheter occlusions are categorized as thrombotic ($50\%\text{ to }60\%$) or non-thrombotic ($40\%\text{ to }50\%$):

• Thrombotic Occlusion Patterns:
  • Intraluminal Thrombus: Occludes the internal lumen; neither infusion nor aspiration is possible.
  • Fibrin Tail: A clot attached to the catheter tip acting as a one-way valve; permits fluid infusion under pump pressure, but occludes the catheter orifice during aspiration.
  • Fibrin Sheath (Fibrin Sleeve): A fibroepithelial sleeve that forms around the catheter circumference starting at the entry site. A fibrin sheath typically presents as a withdrawal occlusion (fluids infuse freely, but blood cannot be aspirated). Under fluoroscopic dye injection (lineogram), contrast tracks retrogradely back along the outer surface of the catheter shaft and spills into the venous lumen near the entry site, with potential subcutaneous extravasation.
• Thrombolytic Protocol: Instill alteplase (recombinant tissue plasminogen activator, tPA) $2\text{ mg}$ reconstituted in $2\text{ mL}$ sterile water (or a volume equal to $110\%$ of the internal lumen volume). Allow alteplase to dwell for 30 to 120 minutes, then attempt aspiration. If unblocked, a second dose may be instilled and allowed to dwell for up to 4 hours or overnight. Never use excessive force with small syringes ($< 10\text{ mL}$) to avoid catheter rupture.
• Non-Thrombotic Occlusions & Chemical Solvents:
  • Lipid Precipitates: Solidified lipid residues resulting from lipid emulsion disruption. Cleared by instilling $70\%$ ethyl alcohol (ethanol), dwelling for 1 to 2 hours.
  • Acidic Drug and Calcium-Phosphate Precipitates (pH $< 6$): Cleared by instilling $0.1\text{ N hydrochloric acid (HCl)}$.
  • Alkaline Drug Precipitates (pH $> 7$, e.g., phenytoin, ampicillin, bicarbonate): Cleared by instilling $0.1\text{ N sodium bicarbonate}$ or $0.1\text{ N sodium hydroxide}$.